Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Outset Medical, Inc. stock logo
OM
Outset Medical
$13.02
+2.8%
$18.39
$5.85
$25.35
$232.61M2.14228,763 shs112,857 shs
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
$40.90
-1.9%
$34.10
$5.21
$46.58
$350.51M1.2952,359 shs10,410 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$3.37
+3.1%
$4.78
$3.03
$9.33
$55.75M1.34193,282 shs261,948 shs
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
$6.94
+6.3%
$5.83
$4.54
$10.79
$439.35M0.68396,103 shs368,240 shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Outset Medical, Inc. stock logo
OM
Outset Medical
+1.93%-10.14%-34.66%-31.51%-4.03%
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
-2.43%+19.14%+19.90%+21.65%+4,169,999,900.00%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
+2.83%-37.71%-21.39%-32.16%-46.13%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
+2.19%+16.82%+8.83%-2.83%+14.76%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Outset Medical, Inc. stock logo
OM
Outset Medical
1.7008 of 5 stars
3.52.00.00.02.10.80.0
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
1.3705 of 5 stars
2.50.00.00.02.72.50.0
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
2.0523 of 5 stars
3.53.00.00.02.00.00.6
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
2.2557 of 5 stars
3.21.00.00.02.33.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Outset Medical, Inc. stock logo
OM
Outset Medical
3.00
Buy$24.6789.45% Upside
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
3.00
Buy$49.0019.80% Upside
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.00
Buy$8.00137.32% Upside
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
2.33
Hold$9.8341.69% Upside

Current Analyst Ratings Breakdown

Latest SRTS, TMCI, OM, and SNWV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/12/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$12.00 ➝ $8.00
8/8/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$13.00 ➝ $6.00
8/8/2025
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$8.60 ➝ $6.50
8/8/2025
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$9.00 ➝ $6.00
8/7/2025
Outset Medical, Inc. stock logo
OM
Outset Medical
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$21.00 ➝ $22.00
7/29/2025
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$49.00
7/14/2025
Outset Medical, Inc. stock logo
OM
Outset Medical
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$37.00
5/21/2025
Outset Medical, Inc. stock logo
OM
Outset Medical
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSector Perform ➝ Sector Perform$14.00 ➝ $21.00
5/19/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$14.00 ➝ $10.00
5/15/2025
Outset Medical, Inc. stock logo
OM
Outset Medical
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
(Data available from 8/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Outset Medical, Inc. stock logo
OM
Outset Medical
$113.69M2.04N/AN/A$8.50 per share1.53
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
$32.63M10.74N/AN/A($1.72) per share-23.78
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$37.56M1.48$0.46 per share7.36$3.41 per share0.99
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
$209.36M2.09N/AN/A$1.55 per share4.48
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Outset Medical, Inc. stock logo
OM
Outset Medical
-$127.98M-$20.29N/AN/A-82.06%-97.17%-32.84%N/A
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
-$31.37M-$8.25N/AN/A-97.03%N/A-135.15%N/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$6.65M-$0.06N/A14.66N/A-2.26%-1.56%-1.40%N/A
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
-$55.74M-$0.79N/AN/AN/A-23.01%-46.76%-23.35%N/A

Latest SRTS, TMCI, OM, and SNWV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/8/2025Q2 2025
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
-$0.09$0.01+$0.10$0.01$10.14 million$10.16 million
8/7/2025Q2 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.01-$0.06-$0.07-$0.06$9.30 million$7.32 million
8/7/2025Q2 2025
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
-$0.29-$0.28+$0.01-$0.28$47.08 million$47.39 million
5/15/2025Q1 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.04-$0.16-$0.20-$0.16$7.23 million$8.34 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Outset Medical, Inc. stock logo
OM
Outset Medical
N/AN/AN/AN/AN/A
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Outset Medical, Inc. stock logo
OM
Outset Medical
0.63
7.47
6.05
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
N/A
0.43
0.31
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
8.06
5.74
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
0.55
3.52
3.36

Institutional Ownership

CompanyInstitutional Ownership
Outset Medical, Inc. stock logo
OM
Outset Medical
N/A
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
42.53%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
84.08%

Insider Ownership

CompanyInsider Ownership
Outset Medical, Inc. stock logo
OM
Outset Medical
2.40%
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
14.90%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
8.90%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
27.72%
CompanyEmployeesShares OutstandingFree FloatOptionable
Outset Medical, Inc. stock logo
OM
Outset Medical
52017.77 million17.34 millionNot Optionable
Sanuwave Health Inc. stock logo
SNWV
Sanuwave Health
408.57 million7.29 millionN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.45 million14.98 millionOptionable
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
25063.17 million45.66 millionOptionable

Recent News About These Companies

Treace Medical (TMCI) Q2 Revenue Up 7%

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Outset Medical stock logo

Outset Medical NASDAQ:OM

$13.02 +0.35 (+2.76%)
As of 02:43 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Sanuwave Health stock logo

Sanuwave Health NASDAQ:SNWV

$40.90 -0.80 (-1.92%)
As of 02:17 PM Eastern

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$3.37 +0.10 (+3.09%)
As of 02:42 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Treace Medical Concepts stock logo

Treace Medical Concepts NASDAQ:TMCI

$6.94 +0.41 (+6.28%)
As of 02:43 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.